Genetic markers may be increasingly useful in clinical settings to identify risk profiles for coronary artery disease.
Answers are grounded in this paper and cite their sources.
Genetic markers for CAD should not yet alter practice; leaves open need for prospective validation.
Coronary artery disease (CAD) and myocardial infarction (MI) are recognized as leading causes of mortality in developed countries. Although typically associated with behavioral risk factors, such as smoking, sedentary lifestyle, and poor dietary habits, such vascular phenotypes have also long been recognized as being related to genetic background. We review the currently available data concerning genetic markers for CAD in English and non-English articles with English abstracts published between 2003 and 2018. As genetic testing is increasingly available, it may be possible to identify adequate genetic markers representing the risk profile and to use them in a clinical setting.
No takes yet. Share an insight, caveat, or question.
Veljković et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: